# CLONAZEPAM

NDC: 46708-366
Generic name: CLONAZEPAM
Labeler / Manufacturer: Alembic Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, ORALLY DISINTEGRATING
Routes: ORAL
Marketing started: 20190701

FDA application: ANDA211033

## Active ingredients

- CLONAZEPAM: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"46708-366"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=46708-366
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43ee20ce-0015-413c-b230-822e390b02f7